US20040236249A1 - Needle for body fluid tester - Google Patents
Needle for body fluid tester Download PDFInfo
- Publication number
- US20040236249A1 US20040236249A1 US10/880,700 US88070004A US2004236249A1 US 20040236249 A1 US20040236249 A1 US 20040236249A1 US 88070004 A US88070004 A US 88070004A US 2004236249 A1 US2004236249 A1 US 2004236249A1
- Authority
- US
- United States
- Prior art keywords
- needle
- fluid
- testing
- tip
- beveled face
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- PZVPOYBHOPRJNP-UHFFFAOYSA-N CCC(C)(C)CN Chemical compound CCC(C)(C)CN PZVPOYBHOPRJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/008—Interstitial fluid
Definitions
- This invention pertains to testing a body fluid for an analyte. More specifically, the present invention pertains to a novel needle design in combination with a collection apparatus for collecting a sample of such a fluid.
- testing for analytes typically requires a fluid sample in excess of a predetermined minimum volume.
- a test may require a minimum sample size of about 1 to 5 ⁇ l to yield reliable test results.
- the '973 patent shows a small diameter needle (about 28 to 32 gauge or about 0.36 mm to 0.23 mm outside diameter) with a length to penetrate into but not through a dermis to access interstitial fluid contained within the dermis.
- the fluid is blood-free to facilitate subsequent testing of the fluid for analytes such as glucose.
- the present invention is directed to an apparatus for collecting a body fluid for testing for an analyte contained within said body fluid.
- the apparatus comprises a needle for penetrating a patient's skin to access the fluid within said skin.
- the needle has a hollow body extending from a first end to a second end with a fluid pathway extending between the ends.
- the second end is positioned to deposit fluid for testing.
- the first end is configured to penetrate the skin and includes a beveled face on a front side of said body.
- the beveled face terminates at a penetration tip.
- the beveled face has an opening in communication with the fluid pathway.
- the body has a linear axis adjacent the first end.
- the first end includes a bend formed on the front side of the beveled face to be deflected toward said front side.
- FIG. 1 is a side elevation view of a needle contained in a sampler
- FIG. 2 is a side sectional view of a needle positioned relative to an absorbent membrane
- FIG. 3 is a side elevation view of a needle being bent
- FIG. 4 is a top plan view of a bent needle
- FIG. 5 is a view taken along line 5 - 5 of FIG. 4;
- FIG. 5A is an end view of a discharge end of a bent needle
- FIG. 5B is a view taken along lines 5 B- 5 B of FIG. 5A and providing an enlarged view of a bent tip of the needle of FIG. 5 and showing a preferred embodiment with the tip bent above the needle;
- FIG. 6 is a side sectional view of a tip of a prior art needle
- FIG. 7 is a top plan view of the needle tip shown in FIG. 6.
- FIG. 8 is a side elevation view of the needle shown in FIGS. 6 and 7 following dulling of the needle tip;
- FIG. 9 is a graphical representation of a collection rate as a function of needle tip displacement for a needle such as that shown in FIGS. 5A and 5B;
- FIG. 10 is a scatter chart of a collection rate as a function of the bend angle of a needle tip for a needle such as that shown in FIGS. 5A and 5B.
- FIG. 1 illustrates a fluid sampler 410 such as that shown in FIGS. 36-40 of U.S. Pat. No. 5,823,973 (the '973 patent), the disclosure of which is hereby incorporated herein by reference.
- FIG. 2 illustrates a membrane and needle assembly such as that shown in FIG. 43 of the '973 patent.
- the present invention will be described to a needle alignment such as that shown in the '973 patent with the axis of the needle parallel to the surface of an absorbing membrane.
- the invention could also be used in other arrangements.
- the needle axis can be perpendicular to the membrane and fluid can flow through the membrane to an opposite side for colormetric testing.
- the sampler 410 has a hollow handle end 409 with an interior 500 to receive a sample end 411 .
- the sample end 411 pivots on a pin 502 .
- the sample end 411 then can pivot between a storage position within the hollow handle end 409 and a deployed position.
- FIG. 1 shows the sample end 411 pivoted into the deployed position.
- the sample end 411 is configured to receive samples such as a fluid.
- An absorbent membrane 504 is carried on the sample end 411 .
- the sample end 411 also includes a hub or ferrule 506 that terminates at a ring end 508 .
- the ring end may serve as a pressure ring.
- a needle 510 is held by the ferrule 506 .
- the sample end 411 defines a hole 604 (FIG. 2).
- An absorbent membrane 504 has a target area T and is arranged so that the target area T overlies the hole 604 .
- the needle 510 includes a hollow, straight tubular body 514 , a first or penetration end 600 , and a discharge end 601 (shown in FIGS. 1 and 2).
- the needle 510 is a 30 gauge needle, about 0.3 mm in outside diameter, although other needle gauges can be used.
- the penetration end 600 protrudes from the ring end 508 of the ferrule by a predetermined distance. The predetermined distance is set so that the first end 600 will penetrate into, but not through, a patient's dermis when the ring 508 is placed against his or her skin.
- the discharge end 601 abuts an absorbent membrane 504 mounted on the sample end 411 .
- the longitudinal axis of the needle 510 is perpendicular to the portion of the membrane 504 that forms the target area T.
- the tubular body 514 has an interior surface 511 (FIG. 5) that defines a fluid pathway 512 extending completely through the needle body 514 .
- the penetration end 600 of the needle 510 is inserted into the patient's dermis. Fluid then flows along the fluid pathway 512 and through the absorbent membrane 504 to the target area T.
- the absorbent membrane 504 filters out undesirable stray blood cells that may be present in the fluid.
- the fluid at the target area can then be tested for elements such as glucose.
- test the fluid is through the use of infrared light.
- Alternative embodiments include but are not limited to depositing the fluid on a test strip for colormetric testing or on electrodes for electrochemical testing.
- the needle 510 has a primary beveled face 520 and tip 530 formed at its penetration end 600 .
- An entrance hole 521 is formed in the beveled face 520 and is in fluid communication with the fluid path 512 .
- the needle 510 also has a front side 522 and an opposite back side 523 .
- the tip 530 of the needle 510 is displaced toward the front side 522 of the needle 510 .
- one possible way to form the needle 510 is as follows.
- the penetration end 600 of the hollow body 514 is ground at an angle to define the beveled face 520 so that it extends through the body 514 and forms the sharp penetration tip 530 .
- the beveled face is formed at an angle ⁇ (about 9°) with respect to a longitudinal axis CL-CL of the needle body 514 .
- the formation of a beveled face 520 results in formation of the entrance hole 521 on beveled face 520 .
- the present invention is shown with a needle having a single grind forming the beveled face.
- the present invention is also applicable to needles with multiple grinds forming the beveled face.
- a fulcrum 700 is placed at a bend location, which is a distance X from the tip 530 .
- the distance X is about 1.2 mm, although other distances can be used.
- the tip 530 is then urged toward the front side 522 to permanently displace the tip 530 and form a bend angle ⁇ .
- the tip 530 moves from being aligned with a plane of the back side 523 of the body 514 to a location spaced by a distance Y from the plane of the back side 523 .
- This method creates an arcuate bend which is approximated in the Figures by the bend angle ⁇ .
- the bend angle ⁇ is about 27.1°, although other bend angles are possible.
- the use of a displaced tip 530 results in enhanced fluid collection. Possibly, a pocket is formed around the opening 521 to improve fluid flow. Whatever the mechanism, fluid collection is enhanced. Further, the degree of enhancement improves with the amount of deflection Y.
- the following table illustrates the amount of time required to collect an adequate sample (in the test presumed to be about 0.9 ⁇ l of fluid) for an average of needle samples at various tip displacements Y and for a variety of axial locations X (with X and Y as defined with reference to FIG. 3 ). The amount of time greatly decreases with an increase in Y. In fact, displacement of the tip above the front plane of the needle body has resulted in enhanced collection.
- FIGS. 5A and 5B illustrate a preferred embodiment where the tip 530 ′′ is displaced above the front side 522 ′′ of the needle 510 ′′.
- elements in common with those of the embodiment of FIGS. 3-5 are similarly numbered (and need not be separately discussed beyond what follows) with the addition of a double apostrophe to distinguish the embodiments.
- the needle 510 ′′ is 0.012 inch (about 0.3048 mm or 30 gauge) outside diameter.
- the preferred embodiment was derived following experimentation subsequent to that enumerated in the above table.
- the bend angle ⁇ is the lesser included angle of a straight line A tangent to the bent portion 600 ′′ and an extension line B of the straight portion.
- the distance Y is the distance between the tip 530 ′′ and the straight line extension B.
- the distance X is the distance from the intersection of the tangent line A and straight line extension B to the tip 530 ′′.
- FIG. 9 is a graphical representation of the collection rate ( ⁇ l/sec.) as a function of the Y displacement (where Y is the average Y values for various angles from the data in FIG. ⁇ ).
- FIG. 10 is a scatter chart of the data plotted as collection rate ( ⁇ l/sec.) as a function of the bend angle ⁇ .
- the fluid in certain applications (for example, collecting interstitial fluid for testing), it is desirable for the fluid to have a low blood content so as to be substantially blood-free.
- substantially blood free it is meant a sample with a hemocrit content of less than 10%.
- the present needle 510 ′′ can also be used to collect higher blood content samples. In both, the design as described increases flow rate while retaining a low pain quality.
- the needle 510 is dulled at the penetration end.
- the dulled edges at the penetration end have benefits separate from the displaced tip described above. Specifically, the dulled edges are found to reduce the amount of unwanted blood in a collected sample of interstitial fluid.
- FIGS. 6-8 illustrate a needle having a straight tip before and after its edges are dulled. Although the dulled edges are illustrated on a needle having a straight tip, they also could be used in conjunction with a displaced tip as described above. Elements and structures that are in common with the embodiments described above are marked with the same reference numerals with the addition of an apostrophe.
- the beveled face 520 ′ is initially formed by grinding the needle 514 ′ at the penetration end 600 ′ as discussed above to form opening 521 ′ (shown in FIG. 7).
- This grinding forms an outer peripheral edge 630 ′, which is defined by the intersection of the beveled face 520 ′ and the outer surface of the cylindrical body 514 ′.
- an inner peripheral edge 632 ′ is defined by the intersection of the beveled face 520 ′ and the interior surface 511 ′ of the needle body 514 ′.
- the inner and outer peripheral edges 630 ′ and 632 ′ and tip 530 ′ are initially sharp (i.e., are formed at substantially non-rounded intersections).
- the inner and outer edges 630 ′ and 632 ′ and tip 530 ′ are dulled so that they become burnished or radiused.
- the dulled edges are formed in a burnishing operation by tumbling the needle 510 ′ in a tumbler with a polishing medium.
- the polishing medium is a fine media such as 1 mm ceramic spheres and a soap solution.
- About 5,000 needles are tumbled in a single batch in the polishing medium for about 20 minutes.
- Other possible tumbling methods use a different polishing medium, different batch sizes, or different lengths of time.
- this process dulls the inner and outer edges 630 ′ and 632 ′ and tip 530 ′.
- the edges 630 ′ and 632 ′ and tip 530 ′ are dulled to a radius of about 0.002 inch or about 0.05 mm.
- a burnishing process is described herein, manufacturing processes other than tumbling may be used to form the dulled edges.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Insulated Conductors (AREA)
- Eye Examination Apparatus (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
An apparatus for collecting a body fluid for testing for an analyte includes a needle for penetrating a patient's skin to access the fluid within the skin. The needle has a hollow body extending from a first end to a second end. An interior surface of the body defines a fluid pathway extending between the ends. The second end is positioned to deposit fluid for testing. The first end has a beveled face on a front side of the body. The beveled face terminates at a penetration tip with the beveled face having an opening in communication with the fluid pathway. The penetration tip is burnished to a rounded shape and bent to facilitate low pain and rapid fluid collection.
Description
- The present application is a continuation-in-part of U.S. patent application Ser. No. 09/244,952 filed Feb. 4, 1999, the disclosure of which is hereby incorporated by reference.
- This invention pertains to testing a body fluid for an analyte. More specifically, the present invention pertains to a novel needle design in combination with a collection apparatus for collecting a sample of such a fluid.
- Numerous patents teach various ways for collecting a sample of body fluid and testing such fluid for an analyte such as glucose. For example, U.S. Pat. Nos. 5,820,570 and 5,823,973 describe methods and apparatus for obtaining, in one embodiment, interstitial fluid which is tested for glucose through IR absorption. These patents also describe use of the disclosed inventions in colormetric and electro-chemical testing of glucose.
- Present development efforts are directed to testing very small volumes of body fluid (e.g. about 0.5 μl). The use of such small volumes of fluid permits less painful collection of a fluid samples. However, small fluid volumes present additional challenges for analyte testing. For example, testing for analytes typically requires a fluid sample in excess of a predetermined minimum volume. By way of non-limiting representative example, a test may require a minimum sample size of about 1 to 5 μl to yield reliable test results.
- The '973 patent shows a small diameter needle (about 28 to 32 gauge or about 0.36 mm to 0.23 mm outside diameter) with a length to penetrate into but not through a dermis to access interstitial fluid contained within the dermis. Preferably, the fluid is blood-free to facilitate subsequent testing of the fluid for analytes such as glucose.
- The use of a small needle dimensioned as described in the '973 patent greatly reduces pain. However, pain may occasionally occur. Further, there is a need for a needle design that enhances the rate at which a sample is collected by such a needle.
- The present invention is directed to an apparatus for collecting a body fluid for testing for an analyte contained within said body fluid. The apparatus comprises a needle for penetrating a patient's skin to access the fluid within said skin. The needle has a hollow body extending from a first end to a second end with a fluid pathway extending between the ends. The second end is positioned to deposit fluid for testing. The first end is configured to penetrate the skin and includes a beveled face on a front side of said body. The beveled face terminates at a penetration tip. The beveled face has an opening in communication with the fluid pathway. The body has a linear axis adjacent the first end. The first end includes a bend formed on the front side of the beveled face to be deflected toward said front side.
- FIG. 1 is a side elevation view of a needle contained in a sampler;
- FIG. 2 is a side sectional view of a needle positioned relative to an absorbent membrane;
- FIG. 3 is a side elevation view of a needle being bent;
- FIG. 4 is a top plan view of a bent needle;
- FIG. 5 is a view taken along line5-5 of FIG. 4;
- FIG. 5A is an end view of a discharge end of a bent needle;
- FIG. 5B is a view taken along
lines 5B-5B of FIG. 5A and providing an enlarged view of a bent tip of the needle of FIG. 5 and showing a preferred embodiment with the tip bent above the needle; - FIG. 6 is a side sectional view of a tip of a prior art needle;
- FIG. 7 is a top plan view of the needle tip shown in FIG. 6; and
- FIG. 8 is a side elevation view of the needle shown in FIGS. 6 and 7 following dulling of the needle tip;
- FIG. 9 is a graphical representation of a collection rate as a function of needle tip displacement for a needle such as that shown in FIGS. 5A and 5B; and
- FIG. 10 is a scatter chart of a collection rate as a function of the bend angle of a needle tip for a needle such as that shown in FIGS. 5A and 5B.
- Various embodiments of the present invention, including a preferred embodiment, will be described in detail with reference to the drawings wherein like reference numerals represent like parts and assemblies throughout the several views. Reference to the described embodiments does not limit the scope of the invention, which is limited only by the scope of the appended claims.
- Throughout the following description, an embodiment of the present invention will be described with reference to collecting a sample of interstitial fluid for glucose testing using a narrow needle that penetrates into, but not through, the dermis. Such sample collection is more fully described in commonly assigned U.S. Pat. Nos. 5,823,973 and 5,820,570, the disclosures for both of which are hereby incorporated by reference as though set forth in full. While such a use is a preferred embodiment, the present invention is applicable to other fluid collection systems as well as testing for other fluid analytes.
- FIG. 1 illustrates a
fluid sampler 410 such as that shown in FIGS. 36-40 of U.S. Pat. No. 5,823,973 (the '973 patent), the disclosure of which is hereby incorporated herein by reference. FIG. 2 illustrates a membrane and needle assembly such as that shown in FIG. 43 of the '973 patent. For ease of illustration, the present invention will be described to a needle alignment such as that shown in the '973 patent with the axis of the needle parallel to the surface of an absorbing membrane. The invention could also be used in other arrangements. For example, the needle axis can be perpendicular to the membrane and fluid can flow through the membrane to an opposite side for colormetric testing. - Referring now to FIGS. 1 and 2, the
sampler 410 has ahollow handle end 409 with an interior 500 to receive asample end 411. The sample end 411 pivots on apin 502. Thesample end 411 then can pivot between a storage position within thehollow handle end 409 and a deployed position. FIG. 1 shows thesample end 411 pivoted into the deployed position. - The
sample end 411 is configured to receive samples such as a fluid. Anabsorbent membrane 504 is carried on thesample end 411. Thesample end 411 also includes a hub orferrule 506 that terminates at aring end 508. In one possible embodiment, the ring end may serve as a pressure ring. Aneedle 510 is held by theferrule 506. Additionally, thesample end 411 defines a hole 604 (FIG. 2). Anabsorbent membrane 504 has a target area T and is arranged so that the target area T overlies thehole 604. - As shown in FIG. 3, the
needle 510 includes a hollow, straighttubular body 514, a first orpenetration end 600, and a discharge end 601 (shown in FIGS. 1 and 2). In one embodiment, theneedle 510 is a 30 gauge needle, about 0.3 mm in outside diameter, although other needle gauges can be used. In a preferred embodiment, thepenetration end 600 protrudes from thering end 508 of the ferrule by a predetermined distance. The predetermined distance is set so that thefirst end 600 will penetrate into, but not through, a patient's dermis when thering 508 is placed against his or her skin. - The
discharge end 601 abuts anabsorbent membrane 504 mounted on thesample end 411. In this configuration, the longitudinal axis of theneedle 510 is perpendicular to the portion of themembrane 504 that forms the target area T. Additionally, thetubular body 514 has an interior surface 511 (FIG. 5) that defines afluid pathway 512 extending completely through theneedle body 514. - In use, the
penetration end 600 of theneedle 510 is inserted into the patient's dermis. Fluid then flows along thefluid pathway 512 and through theabsorbent membrane 504 to the target area T. Theabsorbent membrane 504 filters out undesirable stray blood cells that may be present in the fluid. The fluid at the target area can then be tested for elements such as glucose. - One possible way to test the fluid is through the use of infrared light. Alternative embodiments include but are not limited to depositing the fluid on a test strip for colormetric testing or on electrodes for electrochemical testing.
- Referring to FIGS. 4 and 5, the
needle 510 has a primarybeveled face 520 andtip 530 formed at itspenetration end 600. Anentrance hole 521 is formed in thebeveled face 520 and is in fluid communication with thefluid path 512. Theneedle 510 also has afront side 522 and an oppositeback side 523. Thetip 530 of theneedle 510 is displaced toward thefront side 522 of theneedle 510. - Referring to FIG. 3, one possible way to form the
needle 510 is as follows. Thepenetration end 600 of thehollow body 514 is ground at an angle to define thebeveled face 520 so that it extends through thebody 514 and forms thesharp penetration tip 530. In one possible embodiment, the beveled face is formed at an angle β (about 9°) with respect to a longitudinal axis CL-CL of theneedle body 514. The formation of abeveled face 520 results in formation of theentrance hole 521 onbeveled face 520. The present invention is shown with a needle having a single grind forming the beveled face. The present invention is also applicable to needles with multiple grinds forming the beveled face. - After providing a
needle body 514 with a flatbeveled face 520, afulcrum 700 is placed at a bend location, which is a distance X from thetip 530. In one possible embodiment, the distance X is about 1.2 mm, although other distances can be used. Thetip 530 is then urged toward thefront side 522 to permanently displace thetip 530 and form a bend angle α. When thetip 530 is displaced, it moves from being aligned with a plane of theback side 523 of thebody 514 to a location spaced by a distance Y from the plane of theback side 523. This method creates an arcuate bend which is approximated in the Figures by the bend angle α. In one possible embodiment, the bend angle α is about 27.1°, although other bend angles are possible. - For reasons not fully understood, the use of a displaced
tip 530 results in enhanced fluid collection. Possibly, a pocket is formed around theopening 521 to improve fluid flow. Whatever the mechanism, fluid collection is enhanced. Further, the degree of enhancement improves with the amount of deflection Y. The following table illustrates the amount of time required to collect an adequate sample (in the test presumed to be about 0.9 μl of fluid) for an average of needle samples at various tip displacements Y and for a variety of axial locations X (with X and Y as defined with reference to FIG. 3). The amount of time greatly decreases with an increase in Y. In fact, displacement of the tip above the front plane of the needle body has resulted in enhanced collection. In the following table, negative values of a and Y reflect a backward bending of the tip behind the rear side of the needle. Zero values reflect an unbent needle.TABLE A Time to Collect Pre-determined Amount of Sample Location Angle Displacement Time to Collect X α Y .9 μl of Sample (mm) (degrees) (mm) (seconds) 1.07 −6.03 −0.14 26.75 0 0 0 15.51 0.88 3.24 0.09 12.75 1.57 5.71 0.13 10.41 0.86 11.3 0.15 11.46 2.03 8.13 0.25 12.74 1.30 12.8 0.279 9.04 0.59 28.3. 0.28 1 7.63 1.68 13.7 0.38 7.96 0.94 25.9 0.43 6.62 1.41 21.6 0.51 5.66 - FIGS. 5A and 5B illustrate a preferred embodiment where the
tip 530″ is displaced above thefront side 522″ of theneedle 510″. In FIGS. 5A and 5B, elements in common with those of the embodiment of FIGS. 3-5 are similarly numbered (and need not be separately discussed beyond what follows) with the addition of a double apostrophe to distinguish the embodiments. - The
needle 510″ is 0.012 inch (about 0.3048 mm or 30 gauge) outside diameter. The preferred embodiment was derived following experimentation subsequent to that enumerated in the above table. In FIG. 5B, the bend angle θ is the lesser included angle of a straight line A tangent to thebent portion 600″ and an extension line B of the straight portion. The distance Y is the distance between thetip 530″ and the straight line extension B. The distance X is the distance from the intersection of the tangent line A and straight line extension B to thetip 530″. All of the data in the following table illustrate fluid collection rate (measured in micro-liters per second, μl/sec.) as measured using a preferred value of X equal to 0.035 inch (about 0.8890 mm). The negative values for θ and Y represent a downward bend. Positive values represent upward bends as illustrated in FIG. 5B. A zero value represents an unbent needle.TABLE B Fluid Collection Rate (Micro-Liters/Second) Bend Angle VALUES of Y (θ) in −.006 inch .000 inch .005 inch .012 inch .016 inch .020 inch degrees (≅−.1524 mm) (≅.0000 mm) (≅.1270 mm) (≅.3048 mm) (≅.4064 mm) (≅.5080 mm) −8.1 0.06 0.0 0.10 4.6 0.13 6.5 0.13 7.1 0.12 7.6 0.10 10.0 0.14 12.2 0.15 12.2 0.13 12.8 0.16 14.9 0.13 16.8 0.13 20.0 0.19 21.6 0.17 21.8 0.16 24.7 0.19 25.6 0.18 26.6 0.15 31.2 0.20 46.4 0.20 - Using the above data, FIG. 9 is a graphical representation of the collection rate (μl/sec.) as a function of the Y displacement (where Y is the average Y values for various angles from the data in FIG. θ). FIG. 10 is a scatter chart of the data plotted as collection rate (μl/sec.) as a function of the bend angle θ.
- The above data show for a small gauge needle, collection rate improves with increases in both the bend angle θ and the displacement Y. In fact, displacements greater than the needle's outside diameter of 0.012 inch (representing a bending of the
tip 530″ above thefront side 522″ of theneedle 510″) shows improved collection rates. - Since pain avoidance is a desirable feature, patients selected to collect the above data were asked to compare pain sensation using the above-configured needles. While pain is subjective, it was surprising to note the patient population did not record appreciable increase in pain until the bend angle θ exceeded 30°—40°. The data suggest optimum design of a low pain needle for maximizing fluid collection rates is to provide a bend angle θ of about 30° and preferably between 20° and 40° with the
tip 530″ of the needle bent above the plane of theneedle 510″. - In certain applications (for example, collecting interstitial fluid for testing), it is desirable for the fluid to have a low blood content so as to be substantially blood-free. By substantially blood free, it is meant a sample with a hemocrit content of less than 10%. Using the
bent needle 510″ as described, the frequency of occurrence of blood in a sample increases compared to a straight needle, but the samples continue to be substantially blood free. Thepresent needle 510″ can also be used to collect higher blood content samples. In both, the design as described increases flow rate while retaining a low pain quality. - In addition to the bend angle described above, the
needle 510 is dulled at the penetration end. The dulled edges at the penetration end have benefits separate from the displaced tip described above. Specifically, the dulled edges are found to reduce the amount of unwanted blood in a collected sample of interstitial fluid. - FIGS. 6-8, illustrate a needle having a straight tip before and after its edges are dulled. Although the dulled edges are illustrated on a needle having a straight tip, they also could be used in conjunction with a displaced tip as described above. Elements and structures that are in common with the embodiments described above are marked with the same reference numerals with the addition of an apostrophe.
- Referring now to FIGS. 6 and 7, the
beveled face 520′ is initially formed by grinding theneedle 514′ at thepenetration end 600′ as discussed above to form opening 521′ (shown in FIG. 7). This grinding forms an outerperipheral edge 630′, which is defined by the intersection of thebeveled face 520′ and the outer surface of thecylindrical body 514′. Additionally, an innerperipheral edge 632′ is defined by the intersection of thebeveled face 520′ and theinterior surface 511′ of theneedle body 514′. Upon grinding the needle to form thebeveled face 520′, the inner and outerperipheral edges 630′ and 632′ andtip 530′ are initially sharp (i.e., are formed at substantially non-rounded intersections). - After the
beveled face 520′ is formed, the inner andouter edges 630′ and 632′ andtip 530′ are dulled so that they become burnished or radiused. The dulled edges are formed in a burnishing operation by tumbling theneedle 510′ in a tumbler with a polishing medium. In one possible embodiment, the polishing medium is a fine media such as 1 mm ceramic spheres and a soap solution. About 5,000 needles are tumbled in a single batch in the polishing medium for about 20 minutes. Other possible tumbling methods use a different polishing medium, different batch sizes, or different lengths of time. - Referring to FIG. 8, this process dulls the inner and
outer edges 630′ and 632′ andtip 530′. In one possible embodiment, theedges 630′ and 632′ andtip 530′ are dulled to a radius of about 0.002 inch or about 0.05 mm. Although a burnishing process is described herein, manufacturing processes other than tumbling may be used to form the dulled edges. - From the foregoing detailed description, the present invention has been described in a preferred embodiment. Modifications and equivalents of such disclosure are intended to be included in the appended claims. For example, the benefits of the displaced tip can be attained without the dulled edges of the needle. Similarly, the benefits of the dulled edges can be attained without the displaced tip of the needle. Additionally, all needles have been shown with a single bevel. Nevertheless, the present invention is applicable to a needle with multiple bevels.
Claims (6)
1-11. (Cancelled)
12. A method for collecting a sample of interstitial fluid from a patient, said method comprising:
providing a needle having a hollow body extending from a first end to a second end with a fluid pathway extending between said ends, said first end configured to penetrate said skin and comprising a beveled face on a front side of said body, an opening within said beveled face in communication with said fluid pathway, and a bend formed on said front side and positioned on said beveled face;
penetrating said first end into and through the dermis of the skin;
accessing interstitial fluid at said opening; and
transporting said interstitial fluid through said hollow body.
13. The method of claim 12 , further comprising positioning said second end to deposit fluid for testing.
14. The method of claim 13 , further comprising absorbing said deposited fluid onto a membrane.
15. The method of claim 13 , wherein said testing is selected from the group consisting of calorimetric testing and electrochemical testing.
16. The method of claim 12 , further comprising pressurizing an area about the penetration site of the needle wherein said accessing of interstitial fluid is facilitated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/880,700 US20040236249A1 (en) | 1999-02-04 | 2004-06-29 | Needle for body fluid tester |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24495299A | 1999-02-04 | 1999-02-04 | |
US09/427,161 US6702791B1 (en) | 1999-02-04 | 1999-10-26 | Needle for body fluid tester |
US10/185,605 US6802199B2 (en) | 1999-02-04 | 2002-06-27 | Needle for body fluid tester |
US10/880,700 US20040236249A1 (en) | 1999-02-04 | 2004-06-29 | Needle for body fluid tester |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/185,605 Continuation US6802199B2 (en) | 1999-02-04 | 2002-06-27 | Needle for body fluid tester |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040236249A1 true US20040236249A1 (en) | 2004-11-25 |
Family
ID=26936915
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/185,605 Expired - Lifetime US6802199B2 (en) | 1999-02-04 | 2002-06-27 | Needle for body fluid tester |
US10/880,700 Abandoned US20040236249A1 (en) | 1999-02-04 | 2004-06-29 | Needle for body fluid tester |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/185,605 Expired - Lifetime US6802199B2 (en) | 1999-02-04 | 2002-06-27 | Needle for body fluid tester |
Country Status (12)
Country | Link |
---|---|
US (2) | US6802199B2 (en) |
EP (2) | EP1579808B1 (en) |
JP (1) | JP2002536042A (en) |
AT (2) | ATE290821T1 (en) |
AU (1) | AU768000B2 (en) |
CA (1) | CA2361062A1 (en) |
DE (2) | DE60018710T2 (en) |
DK (1) | DK1148820T3 (en) |
ES (1) | ES2235842T3 (en) |
HK (1) | HK1078250A1 (en) |
PT (1) | PT1148820E (en) |
WO (1) | WO2000045708A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110295152A1 (en) * | 2010-05-25 | 2011-12-01 | Nextier Corporation | Puncture method, incision needle, puncture needle, needle cap and instrument for blood purification treatment |
WO2016043554A1 (en) * | 2014-09-19 | 2016-03-24 | 연세대학교 산학협력단 | One-touch device for collecting fluid |
US10583245B2 (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7828749B2 (en) | 1996-05-17 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
US7235056B2 (en) | 1996-05-17 | 2007-06-26 | Amira Medical | Body fluid sampling device and methods of use |
US20020010406A1 (en) | 1996-05-17 | 2002-01-24 | Douglas Joel S. | Methods and apparatus for expressing body fluid from an incision |
EP1579814A3 (en) | 1996-05-17 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6702791B1 (en) | 1999-02-04 | 2004-03-09 | Integ, Inc. | Needle for body fluid tester |
US9603741B2 (en) | 2000-05-19 | 2017-03-28 | Michael S. Berlin | Delivery system and method of use for the eye |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
CA2450106A1 (en) * | 2001-06-08 | 2002-12-19 | F. Hoffmann-La Roche Ag | Sampling devices and methods for bodily fluids |
US7316700B2 (en) | 2001-06-12 | 2008-01-08 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US6875613B2 (en) | 2001-06-12 | 2005-04-05 | Lifescan, Inc. | Biological fluid constituent sampling and measurement devices and methods |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US6837988B2 (en) | 2001-06-12 | 2005-01-04 | Lifescan, Inc. | Biological fluid sampling and analyte measurement devices and methods |
DE60238119D1 (en) | 2001-06-12 | 2010-12-09 | Pelikan Technologies Inc | ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
JP4272051B2 (en) | 2001-06-12 | 2009-06-03 | ペリカン テクノロジーズ インコーポレイテッド | Blood sampling apparatus and method |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US6721586B2 (en) | 2001-06-12 | 2004-04-13 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US6793632B2 (en) | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
JP4320255B2 (en) | 2001-09-26 | 2009-08-26 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Portable instrument for collecting body fluids |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US20050049522A1 (en) * | 2002-10-30 | 2005-03-03 | Allen John J | Method of lancing skin for the extraction of blood |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US20040193072A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
US7473264B2 (en) * | 2003-03-28 | 2009-01-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
DE602004028463D1 (en) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
US7258673B2 (en) * | 2003-06-06 | 2007-08-21 | Lifescan, Inc | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US20040253736A1 (en) * | 2003-06-06 | 2004-12-16 | Phil Stout | Analytical device with prediction module and related methods |
US20040249254A1 (en) * | 2003-06-06 | 2004-12-09 | Joel Racchini | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
US20050113739A1 (en) * | 2003-11-21 | 2005-05-26 | Matthias Stiene | Device and method for extracting body fluid |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US20050187525A1 (en) * | 2004-02-19 | 2005-08-25 | Hilgers Michael E. | Devices and methods for extracting bodily fluid |
US6990849B2 (en) | 2004-03-26 | 2006-01-31 | Lifescan, Inc. | Microfluidic analytical system with position electrodes |
US20060013731A1 (en) * | 2004-03-26 | 2006-01-19 | Phil Stout | Microfluidic system with feedback control |
US20050266571A1 (en) * | 2004-03-26 | 2005-12-01 | Phil Stout | Method for feedback control of a microfluidic system |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US20050284773A1 (en) * | 2004-06-29 | 2005-12-29 | Allen John J | Method of preventing reuse in an analyte measuring system |
US20060036187A1 (en) | 2004-06-30 | 2006-02-16 | Hester Vos | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
EP1794585A1 (en) * | 2004-08-31 | 2007-06-13 | Lifescan Scotland Ltd | Method of manufacturing an auto-calibrating sensor |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US20070038148A1 (en) * | 2005-08-11 | 2007-02-15 | Joel Mechelke | Sampling module for extracting interstitial fluid |
US20090082862A1 (en) | 2007-09-24 | 2009-03-26 | Schieber Andrew T | Ocular Implant Architectures |
US8425449B2 (en) | 2009-07-09 | 2013-04-23 | Ivantis, Inc. | Ocular implants and methods for delivering ocular implants into the eye |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
US8734377B2 (en) | 2007-09-24 | 2014-05-27 | Ivantis, Inc. | Ocular implants with asymmetric flexibility |
US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
US20090187143A1 (en) * | 2008-01-18 | 2009-07-23 | Ev3 Inc. | Angled tip catheter |
AU2009221859B2 (en) | 2008-03-05 | 2013-04-18 | Alcon Inc. | Methods and apparatus for treating glaucoma |
EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
CA2766131C (en) | 2009-07-09 | 2017-10-24 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
AU2010310484A1 (en) | 2009-10-23 | 2012-05-10 | Ivantis, Inc. | Ocular implant system and method |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9510973B2 (en) | 2010-06-23 | 2016-12-06 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
TW201206400A (en) | 2010-07-08 | 2012-02-16 | Sanofi Aventis Deutschland | Allowing measurements to be made of a blood sample |
TW201216924A (en) * | 2010-07-08 | 2012-05-01 | Sanofi Aventis Deutschland | Apparatus including a lancet |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
ES2962607T3 (en) | 2015-08-14 | 2024-03-20 | Alcon Inc | Eye implant with pressure sensor |
CN112998706B (en) * | 2015-09-24 | 2023-12-12 | 贝克顿·迪金森公司 | Five-bevel cannula for blood collection device |
WO2017106517A1 (en) | 2015-12-15 | 2017-06-22 | Ivantis, Inc. | Ocular implant and delivery system |
US20230082493A1 (en) * | 2020-01-23 | 2023-03-16 | Sureax, Inc. | Needle devices for accessing lymph nodes and thoracic ducts |
CA3202776A1 (en) | 2021-01-11 | 2022-07-14 | Wayne A. Noda | Systems and methods for viscoelastic delivery |
Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2409979A (en) * | 1946-03-14 | 1946-10-22 | Ralph L Huber | Hypodermic needle |
US2697438A (en) * | 1953-10-16 | 1954-12-21 | Bishop & Co Platinum Works J | Noncoring hypodermic needle |
US2717599A (en) * | 1952-02-18 | 1955-09-13 | Huber Jennie | Needle structure |
US2748769A (en) * | 1953-02-24 | 1956-06-05 | Huber Jennie | Hypodermic needle |
US3872806A (en) * | 1973-02-15 | 1975-03-25 | Dennison Mfg Co | Fastener attachment insertion device needle construction |
US3906932A (en) * | 1974-02-27 | 1975-09-23 | Becton Dickinson Co | Needle point for stopper penetration and method of making it |
US3924617A (en) * | 1973-09-28 | 1975-12-09 | Crinospital Spa | Aspiration and infusion needle |
US4368738A (en) * | 1980-04-05 | 1983-01-18 | Bernd Tersteegen | Cannula |
US4490139A (en) * | 1983-01-28 | 1984-12-25 | Eli Lilly And Company | Implant needle and method |
US4518383A (en) * | 1982-08-06 | 1985-05-21 | Evans John M | Instrument and method for epidural and spinal anaesthesia |
US4753641A (en) * | 1987-09-10 | 1988-06-28 | Vaslow Dale F | Emergency medical needle |
US4788986A (en) * | 1987-03-16 | 1988-12-06 | Harris Jim C | Holder for blood collecting needle |
US4808170A (en) * | 1985-12-16 | 1989-02-28 | Alcon Laboratories, Inc. | Hypotraumatic injection needle useful in ophthalmic surgery |
US4889529A (en) * | 1987-07-10 | 1989-12-26 | B. Braun Melsungen Ag | Needle |
US5290267A (en) * | 1991-01-17 | 1994-03-01 | Fresenius Ag | Hypodermic needle |
US5295980A (en) * | 1989-10-30 | 1994-03-22 | Ersek Robert A | Multi-use cannula system |
US5403296A (en) * | 1989-05-05 | 1995-04-04 | Mohring; Klaus | Puncturing instrument |
US5601475A (en) * | 1994-07-27 | 1997-02-11 | Ethicon, Inc. | Method of manufacturing surgical needles having blunt tips |
US5607401A (en) * | 1991-09-03 | 1997-03-04 | Humphrey; Bruce H. | Augmented polymeric hypodermic devices |
US5810788A (en) * | 1995-11-15 | 1998-09-22 | Racz; Gabor J. | R-X needle |
US5820570A (en) * | 1993-10-13 | 1998-10-13 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5823973A (en) * | 1995-09-08 | 1998-10-20 | Integ, Inc. | Needle assembly for fluid sampler |
US6790791B2 (en) * | 2002-08-15 | 2004-09-14 | Micron Technology, Inc. | Lanthanide doped TiOx dielectric films |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4441373A (en) * | 1979-02-21 | 1984-04-10 | American Hospital Supply Corporation | Collection tube for drawing samples of biological fluids |
US4383530A (en) | 1981-06-05 | 1983-05-17 | John Bruno | Hypodermic needle and method of making needles |
US4799494A (en) | 1986-10-22 | 1989-01-24 | Wang Ko P | Percutaneous aspiration lung biopsy needle assembly |
US5505694A (en) | 1990-08-22 | 1996-04-09 | Tcnl Technologies, Inc. | Apparatus and method for raising a skin wheal |
US5575780A (en) * | 1995-04-28 | 1996-11-19 | Saito; Yoshikuni | Medical hollow needle and a method of producing thereof |
US5871470A (en) * | 1997-04-18 | 1999-02-16 | Becton Dickinson And Company | Combined spinal epidural needle set |
US6702791B1 (en) | 1999-02-04 | 2004-03-09 | Integ, Inc. | Needle for body fluid tester |
-
2000
- 2000-01-26 AT AT00913272T patent/ATE290821T1/en active
- 2000-01-26 DE DE60018710T patent/DE60018710T2/en not_active Expired - Lifetime
- 2000-01-26 CA CA002361062A patent/CA2361062A1/en not_active Abandoned
- 2000-01-26 DK DK00913272T patent/DK1148820T3/en active
- 2000-01-26 AU AU34745/00A patent/AU768000B2/en not_active Ceased
- 2000-01-26 EP EP05075625A patent/EP1579808B1/en not_active Expired - Lifetime
- 2000-01-26 JP JP2000596834A patent/JP2002536042A/en active Pending
- 2000-01-26 DE DE60045351T patent/DE60045351D1/en not_active Expired - Lifetime
- 2000-01-26 ES ES00913272T patent/ES2235842T3/en not_active Expired - Lifetime
- 2000-01-26 PT PT00913272T patent/PT1148820E/en unknown
- 2000-01-26 AT AT05075625T patent/ATE490732T1/en not_active IP Right Cessation
- 2000-01-26 EP EP00913272A patent/EP1148820B1/en not_active Expired - Lifetime
- 2000-01-26 WO PCT/US2000/002086 patent/WO2000045708A1/en active IP Right Grant
-
2002
- 2002-06-27 US US10/185,605 patent/US6802199B2/en not_active Expired - Lifetime
-
2004
- 2004-06-29 US US10/880,700 patent/US20040236249A1/en not_active Abandoned
-
2006
- 2006-01-10 HK HK06100387.5A patent/HK1078250A1/en not_active IP Right Cessation
Patent Citations (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2409979A (en) * | 1946-03-14 | 1946-10-22 | Ralph L Huber | Hypodermic needle |
US2717599A (en) * | 1952-02-18 | 1955-09-13 | Huber Jennie | Needle structure |
US2748769A (en) * | 1953-02-24 | 1956-06-05 | Huber Jennie | Hypodermic needle |
US2697438A (en) * | 1953-10-16 | 1954-12-21 | Bishop & Co Platinum Works J | Noncoring hypodermic needle |
US3872806A (en) * | 1973-02-15 | 1975-03-25 | Dennison Mfg Co | Fastener attachment insertion device needle construction |
US3924617A (en) * | 1973-09-28 | 1975-12-09 | Crinospital Spa | Aspiration and infusion needle |
US3906932A (en) * | 1974-02-27 | 1975-09-23 | Becton Dickinson Co | Needle point for stopper penetration and method of making it |
US4368738A (en) * | 1980-04-05 | 1983-01-18 | Bernd Tersteegen | Cannula |
US4518383A (en) * | 1982-08-06 | 1985-05-21 | Evans John M | Instrument and method for epidural and spinal anaesthesia |
US4490139A (en) * | 1983-01-28 | 1984-12-25 | Eli Lilly And Company | Implant needle and method |
US4808170A (en) * | 1985-12-16 | 1989-02-28 | Alcon Laboratories, Inc. | Hypotraumatic injection needle useful in ophthalmic surgery |
US4788986A (en) * | 1987-03-16 | 1988-12-06 | Harris Jim C | Holder for blood collecting needle |
US4889529A (en) * | 1987-07-10 | 1989-12-26 | B. Braun Melsungen Ag | Needle |
US4753641A (en) * | 1987-09-10 | 1988-06-28 | Vaslow Dale F | Emergency medical needle |
US5403296A (en) * | 1989-05-05 | 1995-04-04 | Mohring; Klaus | Puncturing instrument |
US5295980A (en) * | 1989-10-30 | 1994-03-22 | Ersek Robert A | Multi-use cannula system |
US5290267A (en) * | 1991-01-17 | 1994-03-01 | Fresenius Ag | Hypodermic needle |
US5607401A (en) * | 1991-09-03 | 1997-03-04 | Humphrey; Bruce H. | Augmented polymeric hypodermic devices |
US5820570A (en) * | 1993-10-13 | 1998-10-13 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5601475A (en) * | 1994-07-27 | 1997-02-11 | Ethicon, Inc. | Method of manufacturing surgical needles having blunt tips |
US5823973A (en) * | 1995-09-08 | 1998-10-20 | Integ, Inc. | Needle assembly for fluid sampler |
US5810788A (en) * | 1995-11-15 | 1998-09-22 | Racz; Gabor J. | R-X needle |
US6790791B2 (en) * | 2002-08-15 | 2004-09-14 | Micron Technology, Inc. | Lanthanide doped TiOx dielectric films |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110295152A1 (en) * | 2010-05-25 | 2011-12-01 | Nextier Corporation | Puncture method, incision needle, puncture needle, needle cap and instrument for blood purification treatment |
WO2016043554A1 (en) * | 2014-09-19 | 2016-03-24 | 연세대학교 산학협력단 | One-touch device for collecting fluid |
US10583245B2 (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
US11517663B2 (en) | 2015-02-17 | 2022-12-06 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
Also Published As
Publication number | Publication date |
---|---|
AU768000B2 (en) | 2003-11-27 |
DK1148820T3 (en) | 2005-06-27 |
ATE290821T1 (en) | 2005-04-15 |
EP1148820B1 (en) | 2005-03-16 |
DE60018710T2 (en) | 2006-04-13 |
DE60018710D1 (en) | 2005-04-21 |
EP1579808B1 (en) | 2010-12-08 |
WO2000045708A1 (en) | 2000-08-10 |
JP2002536042A (en) | 2002-10-29 |
EP1579808A1 (en) | 2005-09-28 |
HK1078250A1 (en) | 2006-03-10 |
ATE490732T1 (en) | 2010-12-15 |
DE60045351D1 (en) | 2011-01-20 |
US6802199B2 (en) | 2004-10-12 |
EP1148820A1 (en) | 2001-10-31 |
AU3474500A (en) | 2000-08-25 |
CA2361062A1 (en) | 2000-08-10 |
ES2235842T3 (en) | 2005-07-16 |
US20030060784A1 (en) | 2003-03-27 |
PT1148820E (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6802199B2 (en) | Needle for body fluid tester | |
US6702791B1 (en) | Needle for body fluid tester | |
US20060030788A1 (en) | Apparatus and method for extracting bodily fluid utilizing a flat lancet | |
US9554741B2 (en) | Precision depth control lancing tip | |
JP5179868B2 (en) | Lancet, lancet assembly and lancet sensor combination | |
US8016775B2 (en) | Dual blade lancing test strip | |
US7137957B2 (en) | Interstitial fluid collection and constituent measurement | |
US7476202B2 (en) | Sampling devices and methods utilizing a horizontal capillary test strip | |
US7211052B2 (en) | Flexible test strip lancet device | |
CN1984603A (en) | Multiple tip lancet | |
US20020082521A1 (en) | Alternate-site lancer | |
US20020188185A1 (en) | Percutaneous biological fluid sampling and analyte measurement devices and methods | |
WO2005072610A2 (en) | Lancet and method of manufacturing the same | |
JP2003533323A (en) | Body fluid collection system | |
JPS5930422B2 (en) | biological tissue collector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INTEG, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HILGERS, MICHAEL E.;SCHMIDT, BRUNO J.;REEL/FRAME:015843/0821 Effective date: 19990204 |
|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |